ASP GLOSAIR(TM) Decontamination Technology Undertakes Deep Clean at Royal Liverpool Hospital to Promote Better Patient Care

LONDON, August 31, 2010 - Advanced Sterilization Products (ASP) announced today a partnership with
the Royal Liverpool University Hospital to strengthen their infection
prevention efforts and promote better patient care by utilizing ASP's proven
GLOSAIR(TM) area decontamination technology.

As part of a larger refurbishment project, Royal Liverpool University
Hospital has appointed ASP to perform their deep clean decontamination
service through the use of ASP GLOSAIR(TM) technology, supporting the ongoing
measures undertaken by staff, cleaners and existing ASP infection prevention
solutions used by the hospital. GLOSAIR(TM) Area Decontamination technology
uses a low concentration hydrogen peroxide dry-mist technology which operates
at room temperature to decontaminate a ward or patient room within three
hours of operation time. Its proven efficacy[1] ensures that the safest
possible environment is created for patients and healthcare professionals.
For added convenience, the easy-to-operate ASP GLOSAIR(TM) area
decontamination technology is also available for self-service usage by
healthcare facilities. Healthcare professionals can decontaminate large and
small spaces with ASP GLOSAIR(TM) technology as needed.

The first ward decontamination at the Royal Liverpool University Hospital
has already been successfully completed and 14 additional ward
decontaminations in multiple hospital sites are scheduled over the coming 10
months.

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has
made significant advances in tackling Healthcare Associated Infections
(HCAIs) to date and has been recognised as one of the winners in the
inaugural NHS Liverpool Quality Awards for Innovation and Improvements.

Commenting on the hospital's infection control initiatives, Diane Wake,
Director of Infection Prevention and Control at the Royal Liverpool
University Hospital said: "Patients can be reassured that we are continuing
to see significant falls in the number of C. Diff and MRSA cases. We have
halved our C.Diff rates in the last year. With a greater emphasis on cleaning
and cleaning standards, and the use of innovative solutions as provided by
ASP, we have made tackling hospital infections our top priority. Our current
performance clearly shows that our efforts are making a huge difference; we
have gone from being one of the poorest to one of the best performing trusts
in the country for infection control."

"ASP's GLOSAIR(TM) area decontamination service offers a safe, efficient
and convenient way for healthcare professionals to prevent infection and
improve patient care", said Ronan Wright, Business Unit Director, ASP UK &
Ireland. "We are delighted to see the first of this service being implemented
at the Royal Liverpool University Hospital to bolster their infection control
measures."

While significant progress has been made in recent years to effectively
tackle HCAIs, studies conducted by the National Audit Office and the Health
Protection Agency have shown that they continue to pose a serious threat to
patient safety. Ongoing vigilance is essential to ensuring HCAIs are
appropriately prevented and, when required, contained. ASP offers a range of
innovative solutions that are designed to provide a holistic approach to
infection prevention.

About GLOSAIR(TM) Decontamination Systems

ASP GLOSAIR(TM) Systems use a Hydrogen Peroxide (H2O2) vapor or mist to
decontaminate surfaces and areas not effectively decontaminated by
housekeeping which are effective against pathogens of key concern in
Healthcare Acquired Infections. The ability of the product to decontaminate
quickly and effectively minimises the time that the relevant area - ward or
room - is out of use.

About the Royal Liverpool and Broadgreen University Hospitals NHS Trust

The Trust is one of the largest and busiest hospital trusts in the North
of England with almost one million patients being seen every year. The Trust
provides general hospital services and emergency care to the local community
including a full range of medical, surgical, diagnostic, rehabilitation and
therapy services. These include several nationally and internationally
recognised services such as ophthalmology, hepatobilliary, surgery,
gastroenterology and pathology.

The Trust range of specialist services are provided to people across the
North West of England and include its regional centre of excellence for
nephrology, renal transplantation, cancer surgery, vascular surgery, nuclear
medicine, haematology, lithotripsy, tropical and infectious diseases,
dermatology and dental services. The Trust is one of the top 20 teaching
trusts in the country with well established links to both the University of
Liverpool and John Moores University.

About Advanced Sterilization Products (ASP)

Advanced Sterilization Products (ASP), a division of Johnson & Johnson
Medical Ltd in the UK, is a leading developer of innovative instrument
sterilization, high level disinfection and cleaning technologies. The company
is dedicated to protecting patients, healthcare workers, and the environment
with products that focus as much on safety as they do on efficacy and
cost-effectiveness. Utilizing advanced instrument processing technologies,
these products help customers to promote positive patient outcomes while
controlling costs, increasing productivity and enhancing safety.

1. Andersen et al., Journal of Hospital Infection, 2006.

2. Shapey et al., Journal of Hospital Infection, 2008.

3. Barbut et al., Infection Controland Hospital Epidemiology, 2009.

4. Marty, Revue Hygienes, 2007.

5. Grare et al., Journal of Clinical Microbiology, 2008.

6. Bartels et al., Journal of Hospital Infection, 2008.

    Media:
    ASP - UK Johnson & Johnson Media Relations
    Komel Bajwe
    APCO Worldwide
    +44(0)20-7526-3616
    kbajwe@apcoworldwide.com

Media: ASP - UK Johnson & Johnson Media Relations, Komel Bajwe, APCO Worldwide, +44(0)20-7526-3616, kbajwe at apcoworldwide.com